10 Biggest Price Target Changes For Monday
UBS boosted the price target on Seagate Technology Holdings plc (NASDAQ: STX) from $83 to $105. Seagate shares rose 0.8% to $91.05 in pre-market trading.
HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target to $210
HC Wainwright & Co. analyst Oren Livnat maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $220 to $210.
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among those reporting during the week.
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
GW Pharmaceuticals’ Cannabidiol For Seizures Wins UK Approval
The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals’ cannabidiol as an adjunctive treatment of seizures associated…
Stand Up To Cancer And Jazz Pharmaceuticals Announce A 3-Year, $4M Research Collaboration To Fund Catalyst Research On Hard-To-Treat Cancers
Stand Up To Cancer® (SU2C) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announce a three-year, $4 million research collaboration to explore new opportunities, including lurbinectedin in pediatric solid tumors and
Jazz Pharmaceuticals’ GW Pharmaceuticals Received UK Approval for EPIDYOLEX for the Treatment of Seizures Associated with Tuberous Sclerosis Complex
GW Pharmaceuticals ("GW"), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines and now part of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), today announces that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new indication for GW's cannabidiol as a
Benzinga Pro’s Top 5 Stocks To Watch For Monday, Aug. 9, 2021: DKNG, AMC, PDAC, JAZZ, VUZI
Today's 5 Stock Ideas:
DraftKings (DKNG) - The company announce a deal to buy Golden Nugget Online Gaming (GNOG) for $1.56 billion. Shares of Golden Nugget were Monday morning's biggest